HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Influence of microsatellite instability and KRAS and BRAF mutations on lymph node harvest in stage I-III colon cancers.

Abstract
Lymph node (LN) harvest is influenced by several factors, including tumor genetics. Microsatellite instability (MSI) is associated with improved node harvest, but the association to other genetic factors is largely unknown. Research methods included a prospective series of stage I-III colon cancer patients undergoing ex vivo sentinel-node sampling. The presence of MSI, KRAS mutations in codons 12 and 13, and BRAF V600E mutations was analyzed. Uni- and multivariate regression models for node sampling were adjusted for clinical, pathological and molecular features. Of 204 patients, 67% had an adequate harvest (≥ 12 nodes). Adequate harvest was highest in patients whose tumors exhibited MSI (79%; odds ratio [OR] 2.5, 95% confidence interval [CI] 1.2-4.9; P = 0.007) or were located in the proximal colon (73%; 2.8, 1.5-5.3; P = 0.002). In multiple linear regression, MSI was a significant predictor of the total LN count (P = 0.02). Total node count was highest for cancers with MSI and no KRAS/BRAF mutations. The independent association between MSI and a high LN count persisted for stage I and II cancers (P = 0.04). Tumor location in the proximal colon was the only significant predictor of an adequate LN harvest (adjusted OR 2.4, 95% CI 1.2-4.9; P = 0.01). An increase in the total number of nodes harvested was not associated with an increase in nodal metastasis. In conclusion, number of nodes harvested is highest for cancers of the proximal colon and with MSI. The nodal harvest associated with MSI is influenced by BRAF and KRAS genotypes, even for cancers of proximal location. Mechanisms behind the molecular diversity and node yield should be further explored.
AuthorsMarianne Berg, Marianne Guriby, Oddmund Nordgård, Bjørn S Nedrebø, Terje C Ahlquist, Rune Smaaland, Satu Oltedal, Jon Arne Søreide, Hartwig Kørner, Ragnhild A Lothe, Kjetil Søreide
JournalMolecular medicine (Cambridge, Mass.) (Mol Med) Vol. 19 Issue 1 Pg. 286-93 (Sep 10 2013) ISSN: 1528-3658 [Electronic] England
PMID23979710 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • KRAS protein, human
  • Proto-Oncogene Proteins
  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf
  • Proto-Oncogene Proteins p21(ras)
  • ras Proteins
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Colonic Neoplasms (genetics, pathology)
  • Female
  • Humans
  • Lymph Nodes (pathology)
  • Male
  • Microsatellite Instability
  • Middle Aged
  • Mutation
  • Neoplasm Staging
  • Prognosis
  • Prospective Studies
  • Proto-Oncogene Proteins (genetics)
  • Proto-Oncogene Proteins B-raf (genetics)
  • Proto-Oncogene Proteins p21(ras)
  • Young Adult
  • ras Proteins (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: